Kisqali femara co pack?

Kisqali (ribociclib) and Femara (letrozole) are often used together for certain HR-positive, HER2-negative breast cancers, but whether there is a “co-pack” (a fixed-dose combination in one package) depends on your country and the local pharmaceutical supply.

- In many markets, Kisqali and letrozole are supplied as separate medicines, and patients take them on the prescribed dosing schedule.
- Dosing (general reference, not a change from your doctor’s instructions): ribociclib 600 mg once daily on a 21-on/7-off 28-day cycle, plus letrozole 2.5 mg once daily continuously. For premenopausal women, ovarian suppression is also used as advised by the oncologist.
- Some regions may offer a fixed-dose combination or a co-pack for convenience, but this is not universal. Check with your oncologist or pharmacist in your country to see if a co-pack is available where you are.

If you’re asking about a specific product or country, tell me which country you’re in and I can give more precise info. Also, if you’re currently prescribed this combo, follow your doctor's dosing instructions and talk to your pharmacist if you have questions about packaging.